Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Three patients had Netrin-1 receptor antibodies, two with neuromyotonia and concomitant CASPR2+LGI1 antibodies and one with spontaneous muscle overactivity without electromyography evidence of neuromyotonia.
|
30714278 |
2019 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.
|
29244234 |
2018 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
One patient with CASPR2 had neuromyotonia.
|
29264691 |
2018 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although acquired autoimmune neuromyotonia (NMT) is associated with voltage-gated potassium channel (VGKC)-complex antibodies, to date there has been no systematic study of autoantibodies to the specific antigens leucine-rich glioma inactivated protein 1 (LGI1), contactin-associated protein 2 (CASPR2), and contactin 2 together with the full clinical syndrome, particularly pain and autonomic and central nervous system involvement.
|
30242309 |
2018 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Anti-CASPR2 antibodies have been associated not only with limbic encephalitis but also with neuromyotonia and Morvan syndrome.
|
27432809 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Contactin-associated protein-2 antibodies occur with neuromyotonia and thymoma with the Morvan's syndrome in addition to Netrin 1 receptor antibodies but may not be responsible for peripheral nerve hyperexcitability.
|
28682959 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Some patients are reported to be positive for CASPR2 antibody that may be one of the pathogenic autoantibodies in Isaacs syndrome.
|
28438465 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Autoantibodies against the extracellular domains of the voltage-gated potassium channel (VGKC) complex proteins, leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-2 (CASPR2), are found in patients with limbic encephalitis, faciobrachial dystonic seizures, Morvan's syndrome and neuromyotonia.
|
28115470 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Antibodies against Netrin-1 receptors (DCC and UNC5a) and Caspr2 often coexist and associate with thymoma in patients with neuromyotonia and myasthenia gravis.
|
28251919 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
We also discuss the existence of contactin-associated protein-like 2 (Caspr2) antibodies in NMT patients.
|
27957617 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
These include anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis which may present with orolingual facial dyskinesia and stereotyped movements, CRMP-5 IgG presenting with chorea, anti-Yo paraneoplastic cerebellar degeneration presenting with ataxia, anti-VGKC complex (Caspr2 antibodies) neuromyotonia, opsoclonus-myoclonus-ataxia syndrome, and muscle rigidity and episodic spasms (amphiphysin, glutamic acid decarboxylase, glycine receptor, GABA(A)-receptor associated protein antibodies) in stiff-person syndrome.
|
29097081 |
2017 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.
|
21387375 |
2011 |
Isaacs syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
One patient with limbic encephalitis and antibodies against LGI1 also had antibodies against CASPR2, an autoantigen we identified in some patients with encephalitis and seizures, Morvan's syndrome, and neuromyotonia.
|
20580615 |
2010 |